Agios Pharm (AGIO)
What the price implies
A reverse DCF: instead of guessing a fair value, it asks what growth today's price already assumes. How it works.
Fundamental grade
Five factors scored 1 to 9 from AGIO's latest numbers, weighted into one grade. It describes the business, not whether the stock is a buy.
Key numbers
Results from SEC filings
Fiscal years, from Agios Pharm's 10-K filings. Ten years of the full income statement, balance sheet and cash flow.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0 | $14M | $27M | $36M | $54M |
| Net income | $1.6B | -$232M | -$352M | $674M | -$413M |
| Free cash flow | -$413M | -$314M | -$297M | -$392M | -$377M |
| EPS (diluted) | $26.55 | -$4.23 | -$6.33 | $11.64 | -$7.12 |
| Operating margin | — | -2732.1% | -1459.5% | -1166.5% | -873.9% |
Where the revenue comes from
Revenue by products, fiscal 2022. Every breakdown, year by year.
Superinvestors who own AGIO
From each investor's latest 13F filing (what a 13F shows). 2 of the investors we track hold it.
| Investor | Last quarter | Value | % of portfolio | Quarter |
|---|---|---|---|---|
| Tom Steyer Farallon Capital Management LLC |
Added | $220M | 1.0% | Q2 2026 |
| Cliff Asness AQR Capital Management |
Added | $25M | 0.01% | Q2 2026 |
Insider buying
Open-market purchases by Agios Pharm's executives and directors in the last 12 months, from SEC Form 4 filings. What insider buying tells you.
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Mar 3, 2026 | Gilbert Ray Cisneros, Jr. |
0 | $28.48 | — |
| Dec 11, 2025 | Gilbert Ray Cisneros, Jr. |
0 | $27.46 | — |
Get an alert at your buy price
Pick the price you'd be interested at. We'll email you when AGIO trades at or below it.
New accounts get 7 days of Pro, price alerts included. No card needed.
In the full deep dive
Questions
Are Agios Pharm insiders buying the stock?
2 open-market insider purchases of AGIO in the last 12 months, from SEC Form 4 filings.
Which superinvestors own Agios Pharm?
2 of the superinvestors Investingly tracks hold AGIO in their latest 13F, including Tom Steyer, Cliff Asness.
Companies like Agios Pharm
All Healthcare stocks · Biotechnology stocks · Stock lists
Prices and ratios as of Oct 11, 2026; statements from SEC filings. Information only, not investment advice. Superinvestor holdings come from 13F filings, which are filed up to 45 days after each quarter ends.